Methods for improving diaphragm function
US-2015065525-A1 · Mar 5, 2015 · US
Pharmaceutical composition for prevention and/or treatment of urinary incontinence
US9987279B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9987279-B2 |
| Application number | US-201515509394-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 9, 2015 |
| Priority date | Sep 9, 2014 |
| Publication date | Jun 5, 2018 |
| Grant date | Jun 5, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The problem to be solved by the present invention is to provide a novel pharmaceutical composition for prevention and/or treatment of urinary incontinence, which differs from conventional drugs. The present invention provides a therapeutic agent for prevention and/or treatment of urinary incontinence having 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrole-3-carboxamide or a salt thereof, as an active ingredient.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treatment of urinary incontinence, comprising administering an effective dose of 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrole-3-carboxamide or a salt thereof to a subject in need thereof. 2. A method according to claim 1 , wherein said urinary incontinence is stress urinary incontinence. 3. A method according to claim 1 , wherein said urinary incontinence is mixed urinary incontinence.
Assignees
Inventors
Classifications
Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P5/10) · CPC title
Drugs for disorders of the muscular or neuromuscular system · CPC title
of urine or of the urinary tract, e.g. urine acidifiers · CPC title
having the amino group directly attached to the aromatic ring, e.g. benzeneamine · CPC title
containing three or more hetero rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9987279B2 cover?
- The problem to be solved by the present invention is to provide a novel pharmaceutical composition for prevention and/or treatment of urinary incontinence, which differs from conventional drugs. The present invention provides a therapeutic agent for prevention and/or treatment of urinary incontinence having 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1…
- Who is the assignee on this patent?
- Astellas Pharma Inc, Cytokinetics Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/506. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).